Temporal Glucocorticoid Treatment: Modulation of Periodic Endometrial Responses during Decidualization and Pregnancy in Rats

• Published in: Physiology & behavior 1997-10, Vol.62 (4), p.893-897
• Main Authors: Spencer, Fitzgerald, Chi, Limen, Zhu, Ming-Xia, Gebrelul, Sebhatu
• Format: Article
• Language: English
• Subjects: Animals; Biological and medical sciences; Decidualization; Dexamethasone; Endometrium; Endometrium - drug effects; Female; Fundamental and applied biological sciences. Psychology; Glucocorticoids - pharmacology; Growth responses; Hormone metabolism and regulation; Inhibition; Pregnancy; Pregnancy, Animal - drug effects; Pregnancy. Parturition. Lactation; Pseudopregnancy; Pseudopregnancy - chemically induced; Rats; Rats, Sprague-Dawley; Time Factors; Vertebrates: reproduction
• ISSN: 0031-9384; 1873-507X
• DOI: 10.1016/S0031-9384(97)00259-X

The synthetic glucocorticoid, dexamethasone (Dex) was administered subcutaneously (1.5 mg/day/rat) in 3-days pretreatment regimens (Days 2–4, 4–6, 6–8, 8–10 and 10–12) to pseudopregnant rats in which decidualization was surgically induced and to pregnant rats. Variability in endometrial growth during decidualization and in the fetoplacental homeostasis of pregnancy was assessed at the end of each treatment period (Days 4, 6, 8, 10 and 12). During decidualization, endometrial growth (wet weight, protein and DNA) displayed significant ( p < 0.05) time-dependent inhibitory profiles which rose steeply from Day 4 to Day 6 and declined thereafter to Day 10 in fairly well defined linear patterns. For the endometrial enzymes (isocitrate dehydrogenase, alkaline phosphatase and the matrix metalloproteinases—72 and 92 kDa), although the inhibitory patterns were inconsistent, a Days 6–8 treatment regimen seemed to be critical. By contrast Dex treatment induced progressive inhibition in serum progesterone concentrations from Day 2, to peak levels at Day 12. This indicates that time-related Dex inhibition of endometrial growth appeared not to be progesterone-mediated since the endometrial and progesterone inhibitory profiles were not in synchrony. The inhibitory effect of Dex under the pregnancy status demonstrated that birth potentials, fetal and placental weights, all had similar response patterns which rose from Day 4 to Day 8 and then underwent reductions to Day 12. Collectively, the results indicate that there was time dependency in growth inhibition by Dex at the endometrial and fetoplacental levels. Maximal sensitivity to drug exposure essentially coincided with the immediate post-traumal (decidualization) and postimplantation (pregnancy) periods.